Acurx Pharmaceuticals, Inc. (ACXP): Price and Financial Metrics
ACXP Price/Volume Stats
| Current price | $1.86 | 52-week high | $5.28 |
| Prev. close | $1.88 | 52-week low | $1.52 |
| Day low | $1.83 | Volume | 22,000 |
| Day high | $1.91 | Avg. volume | 92,715 |
| 50-day MA | $2.02 | Dividend yield | N/A |
| 200-day MA | $2.34 | Market Cap | 30.22M |
ACXP Stock Price Chart Interactive Chart >
Acurx Pharmaceuticals, Inc. (ACXP) Company Bio
Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York.
ACXP Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...